Navigation Links
Researchers at IRB Barcelona discover one of the mechanisms that prevents the spread of colon cancer
Date:9/30/2007

The first step in the development of colon cancer is the formation of benign tumours, called adenomas, in the intestine. Over time, these tumours may progress to produce colon cancer if they undergo a series of mutations and genetic alterations. Researchers at IRB Barcelona under the direction of Eduard Batlle, ICREA researcher and head of IRB Barcelonas Oncology Programme, have discovered a new mechanism by which the benign tumour cells receive instructions to grow in confined compartments, and no to invade other areas of the tissue. The description of this new tumour suppression mechanism is reported in the scientific journal Nature Genetics.

The scientists observed that adenomatous tumour cells have special surface receptors, called EphB2 and EphB3, which detect the presence of certain ligands in the healthy tissue that surround them. These receptors and their ligands serve to organize the structure of intestinal tissue. Thanks to the activity of EphB2 and EphB3, the tumour cells are forced to listen to the signals that they receive from their environment. These signals make the benign tumours grow in a confined space, from which they are unable to spread. We knew that these receptors worked as tumour suppressors, but we did not know how. Now we have been able to observe that they compartmentalize the tumour, thereby preventing its spread, explains Batlle.

Until the tumour cells learn to deactivate these receptors, they cannot invade other tissue outside the compartment. Batlle goes on to say, as the tumour cells progress to become malignant, their genetic programme is refined and they remove the signals that block their growth, including these two receptors, which impose positional information.

This study explains one of the key mechanisms of how a benign tumour transforms into a malignant one during the onset of colon cancer. Using experiments performed with animal models and in vitro cells, the scientists determined that the
'/>"/>

Contact: Sonia Armengou
sonia.armengou@irbbarcelona.org
34-934-037-255
Institute for Research in Biomedicine (IRB Barcelona)
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers identify the early makers of Neonatal Sepsis
4. OHSU Researchers Announce New Discovery
5. Researchers Identify Gene Connected To Bipolar Disorder
6. Ecstasy shrinks brain!!-researchers unveil the secrets of MDMA.
7. Researchers trick Alzheimers Enzyme
8. Researchers find new HIV hiding place
9. Gene researchers make Malaria-resistant mosquito
10. New Hair in 15 Days Could Now Be A Possibility Say Researchers
11. Researchers developed world’s smallest toothbrus

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...eved to affect circadian rhythm, , ,... suggests that an internal body clock that goes on... bipolar disorder in children. , The finding r...of 152 children with bipolar disorder, which can m...40 children without the disorder. They linked vari...
(Date:11/27/2009)...v. 27 GSI Group Inc. (Pi...ecision technology products and semiconductor syst... Company,s shareholders has been scheduled for Fri... meeting will be announced in due course. As prev...on notice from Stephen Bershad, a holder of greate...
(Date:11/27/2009)...ch firm Replikins Ltd. today issued its latest bio... It shows that the lethality of the virus has drop...us,s current outbreak in the spring of 2009 to res...1). The H1N1 infectivity count, however, remains i...) November 27, 2009 -- Biotech firm Replikins Ltd....
(Date:11/27/2009)...27 The Gymboree Corporat... CFO/COO, will present at the NASDAQ OMX 23rd Inve...otel in London, England, on Wednesday, December 2,...e broadcast of The Gymboree Corporation,s presenta...ree.com, click on "Our Company" at the bottom of t...
(Date:11/27/2009)..., France, Nov. 27 Team Garmin-Slip...am dedicated to ethical sporting and developing th...today that it will become Team Garmin-Transitions ...sponsor of the team. Transitions Optical is the wo...fering the most advanced photochromic technology i...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3
...ults of their work linking mutations in BRAC2 gene...as published in the Journal of Medical Ethics. //M...velopment of breast and ovarian cancer in women ha...n BRAC2 mutations and increased risk of developmen...
...icking up infections like MRSA if they glucose in ...the recent issue of the journal Thorax.// The...ically ill patients in intensive care who required...re measured in their blood samples and lung secret...
...tterns associated with amusia or tone deafness in ...with other learning disorders like dyslexia. // ..., people who are tone deaf -- in scientific terms,...ired following injury to the brain. In an a...
...red to as meconium aspiration) occurs when a newbo...d during labor and delivery. Meconium is the m...ng pregnancy and is formed from ingested amniotic ...It can cause a partial or complete blockage of the...
...ncet, have proposed treating burst aneurysms with ...2002 the International Subarachnoid Aneurysm Trial...he minimally invasive technique, coiling, was more...ves a craniotomy and clipping of the aneurysm to s...
...ctrons have been implicated in a number of degener...mmunity has been trying hard to protect the body f...mentation with anti-oxidants, substances that coun...could help fight chronic disease. Numerous st...
Other Medicine News:Health News:Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions 2Health News:Platinum Coils To Replace Brain Surgery 2
(Date:11/27/2009)... , SALT LAKE CITY, Nov. 27 /PRNewswire-Firs...al Systems, Inc. (NYSE: VAR ), a premier supplie...ctors, will exhibit its full range of detectors at...ember 29 - December 3, 2009. Varian will also be ...lities as well as specialized cancer treatment tec...
(Date:11/26/2009)... , JOHANNESBURG, South Africa, Nov. 26 /PR...frica Company of the Year Award in the Generic Pha...uth Africa Limited. ,, (Logo: http://www.newsc...e Company of the Year Award, the following criteri...e against key competitors: growth strategy and imp...
(Date:11/25/2009)... , LOVELAND, Colo., Nov. 25 /PRNewswire-Fir... leading provider of advanced diagnostic and spe...ced today agreements with Roche Diagnostics Corpor...iliated consumables for the veterinary market. .../20000622/HESKALOGO ) ,, "Heska and Roche share...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Texas Doctor Files Case Pro Se in U S Supreme Court Against Insurance Giant on Integrity and Unethical Practices 58242 1Texas Doctor Files Case Pro Se in U S Supreme Court Against Insurance Giant on Integrity and Unethical Practices 58242 2Texas Doctor Files Case Pro Se in U S Supreme Court Against Insurance Giant on Integrity and Unethical Practices 58242 3New Cardiovascular Biomarker Available for Scientist in North America 5054 1New Cardiovascular Biomarker Available for Scientist in North America 5054 230th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 130th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 230th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 330th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 4
...Achieves Primary Endpoint Among High-Risk Infants ...n of Medically Attended,Outpatient RSV- Related Lo...7 /PRNewswire-FirstCall/ -- MedImmune, Inc.,today ...e trial,conducted for prevention of respiratory sy...b, the investigational monoclonal antibody,(MAb) a...
...D--(BUSINESS WIRE)--May 10, 2007 - An evaluation o...trogen therapy for the,treatment of vaginal atroph...as just been released by The North American,Menopa...ginal,estrogen for treatment of vaginal atrophy in...The North American Menopause Society,",the documen...
Other Medicine Technology:MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 2MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 3MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 4MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 5MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 6MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 7New Position Statement from The North American Menopause Society,Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in,Postmenopausal Women 2New Position Statement from The North American Menopause Society,Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in,Postmenopausal Women 3
Malis Needle Holders
Vascular Clamps RD-S
Vascular Clamps B-1
Micro Emulsifying Needles
Medicine Products: